Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of manifestations affecting health-related quality of life [1]. In recent years recommendations have been standardized for diagnosis, treatment and target outcome in SLE [2,3]. Based on the 2019 EULAR recommendations, a set of 18 quality of care indicators (QIs) retained by a 12-expert panel have been proposed in order to assess and improve SLE patients care [4]. Tested in a cohort of 220 patients, higher adherence to QIs was associated with a reduced risk for a composite adverse outcome including SLE flare, hospitalization or damage accrual [4].
